These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22945882)

  • 1. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.
    Pawar D; Neve RS; Kalgane S; Riva A; Bombardelli E; Ronchi M; Petrangolini G; Morazzoni P
    Support Care Cancer; 2013 Mar; 21(3):827-34. PubMed ID: 22945882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM).
    Fasanaro E; Del Bianco P; Groff E; Riva A; Petrangolini G; Busato F; Stritoni P; Scarzello G; Loreggian L; De Salvo GL
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
    Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
    Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
    Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMITAL®: a new botanical drug for the treatment of mucositis induced by oncological therapies.
    Morazzoni P; Petrangolini G; Bombardelli E; Ronchi M; Cabri W; Riva A
    Future Oncol; 2013 Nov; 9(11):1717-25. PubMed ID: 24156331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an Indomethacin Oral Spray on Pain Due to Oral Mucositis in Cancer Patients Treated With Radiotherapy and Chemotherapy: A Double-Blind, Randomized, Placebo-Controlled Trial (JORTC-PAL04).
    Nagaoka H; Momo K; Hamano J; Miyaji T; Oyamada S; Kawaguchi T; Homma M; Yamaguchi T; Morita T; Kizawa Y
    J Pain Symptom Manage; 2021 Sep; 62(3):537-544. PubMed ID: 33516927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).
    Leenstra JL; Miller RC; Qin R; Martenson JA; Dornfeld KJ; Bearden JD; Puri DR; Stella PJ; Mazurczak MA; Klish MD; Novotny PJ; Foote RL; Loprinzi CL
    J Clin Oncol; 2014 May; 32(15):1571-7. PubMed ID: 24733799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients.
    Bertoglio JC; Calderón S; Lesina B; Pilleux L; Morazzoni P; Riva A; Bombardelli E; Ronchi M; Cabri W; Petrangolini G
    Future Oncol; 2013 Nov; 9(11):1727-32. PubMed ID: 24156332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
    Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
    Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gastrointestinal mucositis due to cancer therapies in pediatric patients: results of a case series with SAMITAL(®).
    Bertoglio JC; Folatre I; Bombardelli E; Riva A; Morazzoni P; Ronchi M; Petrangolini G
    Future Oncol; 2012 Nov; 8(11):1481-6. PubMed ID: 23148620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
    Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
    Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
    Kia SJ; Basirat M; Saedi HS; Arab SA
    BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
    Allison RR; Ambrad AA; Arshoun Y; Carmel RJ; Ciuba DF; Feldman E; Finkelstein SE; Gandhavadi R; Heron DE; Lane SC; Longo JM; Meakin C; Papadopoulos D; Pruitt DE; Steinbrenner LM; Taylor MA; Wisbeck WM; Yuh GE; Nowotnik DP; Sonis ST
    Cancer; 2014 May; 120(9):1433-40. PubMed ID: 24877167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.